COVID-19 Vaccines Safety Tracking (CoVaST)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMasaryk University

About this trial

This project aims to monitor the side effects of COVID-19 vaccines worldwide actively. The primary objectives of the project include a) to estimate the prevalence of each local and systemic side effect of each COVID-19 vaccine among healthcare workers (HCW), old adults over +65 (OA), and schoolteachers (ST); b) to evaluate the potential demographic and medical risk factors for side effects frequency and intensity; c) to evaluate the long-term consequences of COVID-19 vaccines. The secondary objectives include a) to evaluate the relative safety of COVID-19 vaccines compared to each other; b) to evaluate the impact of palliative drugs used by the recently vaccinated individuals on their short-term side effects resolution.

Eligibility criteria

Qualifiers

HCW, OA and ST who received COVID-19 vaccine.

Participating subjects should be at least 18-year-old and able to give their informed consent independently.

Disqualifiers

Non HCW, OA and ST who received the COVID-19.

Trial design

Treatments tested in this trial

  • BNT162b2
  • mRNA-1273
  • AZD1222
  • CoronaVac
  • Sinopharm
  • Gam-COVID-Vac
  • JNJ-78436735
  • CVnCoV
  • NVX-CoV2373
  • BBV152

Treatment groups

30,000 Participants
are divided into 11 treatment groups

11

Treatment groups

See each treatment group below.

Sponsors and collaborators